Omicron – mild or monster?

As anti-science leaves research reeling, does evidence-based policy in a scientific society have much of a future? Michael Mann, Naomi Oreskes, Angie Rasmussen and Deb Houry discuss some of the sources and motivations that perhaps belie the current state of scientific affairs. Pr ...  Show more

As two species of coral are killed off by the 2023 heatwave in the Florida reefs, the abilities of different plankton species to cope with rising CO2 remain crucially unknown. Also, retrospective research shows a strong suggestion that mRNA covid vaccination might serendipitously ...  Show more

A study from Hong Kong university shows Omicron replicates 70 times faster than two earlier variants of the SARS-Cov-2 virus. Virologist Malik Peiris, explains how tests using cells from the wind pipe showed the dramatic difference, which supports observations of increased transm ...  Show more

When all restrictions are lifted in a highly vaccinated country, how manageable is the coronavirus? Both Israel and UK’s experiments to do just that, have raised new worries about raising the risk of new vaccine resistant variants. Claudia Hammond and her panel of global experts ...  Show more

T-Cells in vaccinated people may be holding the fort, or at least fighting serious illness, against the latest SARS CoV2 variant. Also, how the briefest of sleeps aids creativity.Prof Penny Moore, of South Africa’s National Centre for Infectious Disease and Witwatersrand Universi ...  Show more

Scientists are now looking at the question of third doses of vaccines against SARS-Cov2, and this week the Cov-Boost trial was launched. It’s being run from University of Southampton and is going to be using seven different vaccines, some at half doses, in people over the age of ...  Show more